http://www.denalitherapeutics.com
Denali Therapeutics Inc. Company Intro
Denali Therapeutics is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development.
Industry
Healthcare
Denali Therapeutics Inc. Headquaters
161 Oyster Point Boulevard
South San Francisco,94080
United States
Denali Therapeutics Inc. Share price
14 Sep 2022 09:04 GMT
$30.36
-0.97 (-3.1 %)
Denali Therapeutics Inc. Market cap
$3.653 B
WMC RANKING
2023
Denali Therapeutics Inc. # 129
BiotechnologyLatest Denali Therapeutics Inc. News
28 Mar 2023
Path Ahead For Neuraly's NLY01 Unclear After Phase II ...
Neuraly, Inc.'s lead candidate, NLY01, has failed a Phase II trial in early ... kinase 2 inhibitor BIIB-122 in partnership with Denali Therapeutics Inc..
28 Mar 2023
Path Ahead For Neuraly's NLY01 Unclear After Phase II ...
Neuraly, Inc.'s lead candidate, NLY01, has failed a Phase II trial in early ... kinase 2 inhibitor BIIB-122 in partnership with Denali Therapeutics Inc..
WMC Market Score
WMC Market to Revenue Score
Denali Therapeutics Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Denali Therapeutics Inc. | USD | $339,978 | $288,513 | $57,858 | $36,530B | 129 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Denali Therapeutics Inc. Social Followers vs Top 4 Industry Competitors
Denali Therapeutics Inc. Post vs Top 4 Industry Competitors
Denali Therapeutics Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Denali Therapeutics Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Denali Therapeutics Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Denali Therapeutics Inc. | 3.70 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
